Prognostic Significance of Chromosomal Aberrations in Philadelphia Chromosome Negative Metaphases during Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia

被引：0
|
作者：
Batra, R. [1 ]
Weisenburger, D. [1 ]
Snyder, D. [1 ]
Bedell, V. [1 ]
Murata-Collins, J. [1 ]
Gaal, K. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1380
引用
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [31] Acquired Cytogenetic Aberrations in Philadelphia Chromosome Negative Cells from Patients with Chronic Myelogenous Leukemia Not Associated with Definitive Myelodysplasia
    Bulkeley, W. W.
    Shah, B.
    Zhang, X.
    Pinilla-Ibarz, J.
    Zhang, L.
    LABORATORY INVESTIGATION, 2011, 91 : 287A - 288A
  • [32] ADDITIONAL CHROMOSOME ABERRATIONS IN CHRONIC MYELOID LEUKEMIA PATIENTS UNDERGOING TYROSINE KINASE INHIBITORS THERAPY
    Neverova, L.
    Zakharova, A.
    Udovichenko, A.
    Turkina, A.
    Khoroshko, N.
    Alimova, G.
    Kleina, I.
    Dyachenko, L.
    Konnova, M.
    Timofeeva, N.
    Obukhova, T.
    Aseeva, E.
    Vinogradova, O.
    Kremenetskaya, O.
    Domracheva, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 344 - 344
  • [33] DISTRIBUTION OF PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
    WHANG, J
    FREI, E
    CARBONE, PP
    BRECHER, G
    TJIO, JH
    BLOOD, 1963, 22 (06) : 664 - &
  • [34] STUDIES OF PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
    FREI, E
    CARBONE, PP
    WHANG, J
    TJIO, JH
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1964, 113 (A2) : 1073 - &
  • [35] Chromosomal abnormalities in Philadelphia chromosome (Ph)-negative metaphases appearing during imatinib mesylate (IM) therapy in patients (pts) with newly diagnosed chronic myeloid leukemia (CML) in chronic phase.
    Jabbour, E
    Kantarjian, H
    O'Brien, S
    Verstovsek, S
    Garcia-Manero, G
    Rioss, MB
    Cortes, J
    BLOOD, 2005, 106 (11) : 317A - 318A
  • [36] Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia
    Onida, F
    Ball, G
    Kantarjian, HM
    Smith, TL
    Glassman, A
    Albitar, M
    Scappini, B
    Rios, MB
    Keating, MJ
    Beran, M
    CANCER, 2002, 95 (08) : 1673 - 1684
  • [37] Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy
    Berman, Ellin
    Druker, Brian J.
    Burwick, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (12) : 1250 - +
  • [38] Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
    Zimu Gong
    Lan Zheng
    Zhenya Tang
    Zi Chen
    Wei Wang
    Shi Bai
    Guilin Tang
    L. Jeffrey Medeiros
    Shimin Hu
    Annals of Hematology, 2017, 96 : 1239 - 1239
  • [39] Results of Second Generation Tyrosine Kinase Inhibitor Frontline Therapy in Chronic Myeloid Leukemia with Variant Philadelphia Chromosome
    Romo, Carlos G.
    Kantarjian, Hagop M.
    O'Brien, Susan
    Quintas-Cardama, Alfonso
    Kornblau, Steven M.
    Faderl, Stefan
    Ferrajoli, Alessandra
    Wierda, William G.
    Pierce, Sherry A.
    Jabbour, Elias J.
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [40] Clinical Importance of Drug Adherence during Tyrosine Kinase Inhibitor Therapy for Chronic Myelogenous Leukemia in Chronic Phase
    Maeda, Yasuhiro
    Okamoto, Atsushi
    Yamamoto, Kenta
    Eguchi, Go
    Kanai, Yoshitaka
    REPORTS, 2019, 2 (04)
12345